In the identical yr the ITC also noted on their own endeavours in direction of the circulation syntheses of two direct compounds reported previously by AstraZeneca. The initial one aspects the flow synthesis of a strong 5HT1B antagonist (28) that was assembled by way of a 5 step continuous synthesis such as a SNAr reaction, heterogeneous hydrogenat